Molina Healthcare (NYSE: MOH) insider transactions
In the twelve months to 10 November 2026, executives and directors of Molina Healthcare reported 4 open-market sales of 19,274 shares ($3.6m) and 1 open-market purchase of 800 shares ($100,128), by 5 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 1 October 2026 | Brasier Barbara L | Director | Grant or award | +304 | $180.85 | 6,122 | Form 4 |
| 1 October 2026 | Romney Ronna | Director | Grant or award | +304 | $180.85 | 18,173 | Form 4 |
| 1 October 2026 | Orlando Steven J | Director | Grant or award | +304 | $180.85 | 18,271 | Form 4 |
| 1 October 2026 | Wolf Dale B | Director | Grant or award | +304 | $180.85 | 15,937 | Form 4 |
| 1 October 2026 | Soistman Francis S JR | Director | Grant or award | +304 | $180.85 | 1,211 | Form 4 |
| 1 October 2026 | Grohowski Leo P | Director | Grant or award | +304 | $180.85 | 1,846 | Form 4 |
| 1 October 2026 | Zoretic Richard C | Director | Grant or award | +304 | $180.85 | 9,693 | Form 4 |
| 1 October 2026 | Schapiro Richard M | Director | Grant or award | +304 | $180.85 | 12,615 | Form 4 |
| 1 October 2026 | Lockhart Stephen H | Director | Grant or award | +304 | $180.85 | 4,688 | Form 4 |
| 1 July 2026 | Brasier Barbara L | Director | Grant or award | +237 | $232.55 | 5,818 | Form 4 |
| 1 July 2026 | Romney Ronna | Director | Grant or award | +237 | $232.55 | 17,869 | Form 4 |
| 1 July 2026 | Orlando Steven J | Director | Grant or award | +237 | $232.55 | 17,967 | Form 4 |
| 1 July 2026 | Wolf Dale B | Director | Grant or award | +237 | $232.55 | 15,633 | Form 4 |
| 1 July 2026 | Soistman Francis S JR | Director | Grant or award | +237 | $232.55 | 907 | Form 4 |
| 1 July 2026 | Grohowski Leo P | Director | Grant or award | +237 | $232.55 | 1,542 | Form 4 |
| 1 July 2026 | Zoretic Richard C | Director | Grant or award | +237 | $232.55 | 9,389 | Form 4 |
| 1 July 2026 | Schapiro Richard M | Director | Grant or award | +237 | $232.55 | 12,311 | Form 4 |
| 1 July 2026 | Lockhart Stephen H | Director | Grant or award | +237 | $232.55 | 4,384 | Form 4 |
| 1 July 2026 | Bacon Debra | EVP, Medicaid | Shares withheld for tax | −183 | $232.55 | 21,636 | Form 4 |
| 30 June 2026 | Woys James | Chief Operating Officer | Grant or award | +144 | $147.51 | 90,178 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Molina Healthcare page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.